Skip to main content
. 2017 Jul 17;8(47):82144–82155. doi: 10.18632/oncotarget.19285

Figure 3. Selinexor treatment or miR-145 mimic transfection inhibited the proliferation of PDAC cells.

Figure 3

MiaPaCa-2 (A), AsPC-1 (B), PANC-1 (C) and HPAC (D) cells were treated with 500 nM selinexor or transfected with miR-145 mimic or control mimic. The cell proliferation index was measured by MTT assay as described in the section of “Materials and Methods”.